Antisense oligonucleotides as inhibitors of genes that regulate AP-1: Pharmacology and clinical development

被引：7
|
作者：
Dean, NM [1 ]
McKay, RA [1 ]
Holmlund, J [1 ]
机构：
[1] ISIS Pharmaceut, Carlsbad, CA 92008 USA
来源：
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT | 1998年 / 8卷 / 02期
关键词：
D O I：
10.1089/oli.1.1998.8.147
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：147 / 151
页数：5
相关论文
共 50 条
  • [1] Preclinical and clinical pharmacology of antisense oligonucleotides
    E. G. Marcusson
    B. R. Yacyshyn
    W. R. Shanahan
    N. M. Dean
    Molecular Biotechnology, 1999, 12 : 1 - 11
  • [2] Preclinical and clinical pharmacology of antisense oligonucleotides
    Marcusson, EG
    Yacyshyn, BR
    Shanahan, WR
    Dean, NM
    MOLECULAR BIOTECHNOLOGY, 1999, 12 (01) : 1 - 11
  • [3] Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis
    de Wilde, Jillian
    Arce, Johanna De-Castro
    Snijders, Peter J. F.
    Meijer, Chris J. L. M.
    Roesl, Frank
    Steenbergen, Renske D. M.
    CELLULAR ONCOLOGY, 2008, 30 (01) : 77 - 87
  • [4] Identification of AP-1 DNA: Protein inhibitors
    Ferguson, D
    Nouhan, C
    Scholten, JD
    FASEB JOURNAL, 1997, 11 (09): : A1074 - A1074
  • [5] Applying antisense technology -: Affinitak™ and other antisense oligonucleotides in clinical development
    Holmlund, JT
    THERAPEUTIC OLIGONUCLEOTIDES: ANTISENSE, RNAI, TRIPLE-HELIX, GENE REPAIR, ENHANCER DECOYS, CPG AND DNA CHIPS, 2003, 1002 : 244 - 251
  • [6] AP-1 in mouse development and tumorigenesis
    Wolfram Jochum
    Emmanuelle Passegué
    Erwin F Wagner
    Oncogene, 2001, 20 : 2401 - 2412
  • [7] AP-1 in mouse development and tumorigenesis
    Jochum, W
    Passegué, E
    Wagner, EF
    ONCOGENE, 2001, 20 (19) : 2401 - 2412
  • [8] Antitumor activity of decoy oligonucleotides targeted to AP-1 in vitro and in vivo
    Wang, XG
    Ye, Q
    Chen, WL
    Feng, Y
    Wei, C
    Liu, H
    Ouyang, PK
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2004, 31 (01) : 27 - 31
  • [9] Pharmacokinetics and Clinical Pharmacology Considerations of GalNAc3-Conjugated Antisense Oligonucleotides
    Wang, Yanfeng
    Yu, Rosie Z.
    Henry, Scott
    Geary, Richard S.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (06) : 475 - 485
  • [10] IKAROS and AIOLOS directly regulate AP-1 transcriptional complexes and are essential for NK cell development
    Wilford Goh
    Harrison Sudholz
    Momeneh Foroutan
    Sebastian Scheer
    Aline Pfefferle
    Rebecca B. Delconte
    Xiangpeng Meng
    Zihan Shen
    Robert Hennessey
    Isabella Y. Kong
    Iona S. Schuster
    Christopher E. Andoniou
    Melissa J. Davis
    Soroor Hediyeh-Zadeh
    Fernando Souza-Fonseca-Guimaraes
    Ian A. Parish
    Paul Beavis
    Daniel Thiele
    Michael Chopin
    Mariapia A. Degli-Esposti
    Joe Cursons
    Axel Kallies
    Jai Rautela
    Stephen L. Nutt
    Nicholas D. Huntington
    Nature Immunology, 2024, 25 : 240 - 255
12345